Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Aug 8, 2018, after the close
10-Q filed Aug 8, 2018, 39 days after period end · 0001558370-18-006758
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $1.79M | $0.00 | — | — |
| Net Income | -$25.56M | -$19.15M | — | — |
| EPS Diluted | -$0.16 | -$0.16 |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| -$0.15 |
| -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
